Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes a review of clinical effectiveness, cost-effectiveness, and guidelines
This report aims to summarize the comparative clinical effectiveness and comparative cost-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes, as well as relevant evidence-based guidelines for the pharmacologic management of diabetes
Main Authors: | , |
---|---|
Corporate Authors: | , |
Format: | eBook |
Language: | English |
Published: |
Ottawa
CADTH
June 14, 2019, 2019
|
Edition: | Version: 1.0 |
Series: | CADTH rapid response report
|
Subjects: | |
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Summary: | This report aims to summarize the comparative clinical effectiveness and comparative cost-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes, as well as relevant evidence-based guidelines for the pharmacologic management of diabetes |
---|---|
Physical Description: | 1 PDF file (39 pages) illustration |